BMA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient entry: the technical backdrop is constructive, but the latest quarter showed a sharp deterioration (revenue down YoY and a net loss), and options positioning is mixed-to-defensive.", "Price (~98.78 pre-market) is sitting just below the pivot (99.31); upside exists toward 104.9/108.36, but the risk of a drop back toward 93.72/90.26 is meaningful given high volatility and weak fundamentals.", "Net view: HOLD (do not add here); it becomes more compelling only if fundamentals stabilize or price proves strength above ~99.3 and holds."]
["Trend/MAs: Bullish structure with SMA_5 > SMA_20 > SMA_200, implying an established uptrend on moving-average basis.", "Momentum: MACD histogram is positive (0.0812) but contracting\u2014uptrend is losing momentum rather than accelerating.", "RSI: RSI_6 at 48.0 is neutral, consistent with consolidation/indecision near current levels.", "Key levels: Pivot 99.31 (near current price). Resistance: 104.90 then 108.36. Support: 93.72 then 90.26.", "Pattern-based projection (model): High probability skew bullish (90% chance of gains), but this should be weighed against very high realized/expected volatility."]
["Street thesis (UBS/Goldman): Argentine banking seen at an \u201cinflection point\u201d with improving macro backdrop; Banco Macro highlighted for stronger capital position and potentially lower credit-risk profile versus peers.", "Technical structure remains bullish on moving averages; a clean reclaim/hold above ~99.3 could invite momentum toward 104.9+.", "Upcoming event: Earnings on 2026-03-02 after hours (potential catalyst if results confirm stabilization)."]
["Fundamentals weakened materially in the latest reported quarter (Q3 2025): revenue contraction and a swing to net loss raise near-term confidence risk.", "HSBC downgrade to Hold with an $80 target creates an explicit bearish anchor vs the current ~$99 level.", "Options open-interest skew (put-heavy) and elevated IV percentile imply investors are paying up for protection and expecting big swings\u2014often a sign of uncertainty."]
["Latest quarter: 2025/Q3.", "Revenue: 684,123,773.73 (-23.68% YoY), indicating notable top-line pressure.", "Net income: -24,882,825.36 (down -125.75% YoY), showing a move into losses vs prior year.", "EPS: -0.04 (down -126.67% YoY), confirming profit deterioration.", "Overall: Growth trend is negative in the most recent quarter; this undermines the otherwise-bullish technical setup."]
["Recent rating trend: Two bullish initiations (Goldman Buy PT $111; UBS Buy PT $130) followed by a downgrade (HSBC to Hold PT $80).", "Price target picture vs current (~98.78): UBS and Goldman imply upside; HSBC implies downside\u2014Wall Street is split with a wide dispersion (high uncertainty).", "Pros (bull case): Stronger capital ratio vs peers, resilient franchise, potentially lower asset-quality risk if Argentina macro normalizes.", "Cons (bear case): Recent earnings/financial momentum is weak, and at least one major bank sees the stock overextended relative to its fundamentals (HSBC PT $80)."]
